Intellia Therapeutics (NasdaqGM:NTLA) 2026 Conference Transcript

Intellia Therapeutics (NasdaqGM:NTLA) 2026 Conference March 09, 2026 08:40 AM ET Company ParticipantsEdward Dulac - EVP, CFO and TreasurerJohn Leonard - President and CEOConference Call ParticipantsMani Foroohar - Managing Director and Senior Research Analyst – Genetic MedicinesMani ForooharPerfect. Thank you. Welcome back to the next session of this year's Global Healthcare Conference here in Miami. Once again, Mani Foroohar, senior analyst at Leerink Partners. I'm hosting John Leonard and Ed Dulac from In ...